Pages that link to "Q44960106"

The following pages link to A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. (Q44960106):

Displaying 50 items.

• Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB (Q24678394) (← links)
• Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users (Q26768444) (← links)
• The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies (Q28069364) (← links)
• The influence of genetic and environmental factors among MDMA users in cognitive performance (Q28477994) (← links)
• Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users (Q28486090) (← links)
• 5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study (Q28546929) (← links)
• Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use (Q29473848) (← links)
• Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects (Q31033312) (← links)
• Ecstasy: are animal data consistent between species and can they translate to humans? (Q31033315) (← links)
• Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users (Q33374696) (← links)
• Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study (Q33586450) (← links)
• Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study (Q34030711) (← links)
• MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain (Q34280047) (← links)
• Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. (Q34597927) (← links)
• Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users (Q34618285) (← links)
• A long-term ecstasy-related change in visual perception. (Q34622620) (← links)
• Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users (Q34634128) (← links)
• Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. (Q34976260) (← links)
• Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines (Q35010538) (← links)
• Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys (Q35017128) (← links)
• What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? (Q35195505) (← links)
• MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study (Q35415158) (← links)
• Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval (Q35589685) (← links)
• N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study (Q35671537) (← links)
• Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. (Q35854864) (← links)
• Serotonin neurotoxins--past and present (Q36003842) (← links)
• Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users (Q36255067) (← links)
• Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys (Q36312733) (← links)
• Neuroreceptor imaging in psychiatry: theory and applications. (Q36314030) (← links)
• A clinical crossroads for MDMA. (Q36397237) (← links)
• Neuroimaging research in human MDMA users: a review (Q36539089) (← links)
• Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice (Q36596776) (← links)
• Young adult Ecstasy users who forego necessary medical care: a fairly common occurrence with important health implications (Q36596781) (← links)
• MDMA use and neurocognition: a meta-analytic review (Q36643639) (← links)
• Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats (Q36742799) (← links)
• Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms? (Q36831009) (← links)
• The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls (Q36978299) (← links)
• Factors associated with condom use among young adult ecstasy users (Q37071118) (← links)
• Neuropsychological function in ecstasy users: a study controlling for polydrug use. (Q37123827) (← links)
• A review of the stereotype threat literature and its application in a neurological population (Q37139472) (← links)
• The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings (Q37141888) (← links)
• Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent ( /-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance (Q37461894) (← links)
• Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation (Q37789757) (← links)
• The effects of 'ecstasy' (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses (Q37990456) (← links)
• The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users (Q38376332) (← links)
• The relationships of 'ecstasy' (MDMA) and cannabis use to impaired executive inhibition and access to semantic long-term memory (Q38484913) (← links)
• MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. (Q40007746) (← links)
• Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats (Q40323547) (← links)
• The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. (Q40360036) (← links)
• MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. (Q40362823) (← links)